Comparative analysis of paricalcitol and cinacalcet with low-dose vitamin D for treating secondary hyperparathyroidism in hemodialysis patients based on the IMPACT SHPT study.
Exploring how hemodialysis and peritoneal dialysis differently impact secondary hyperparathyroidism in end-stage renal disease patients.